𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk factors for development of symptoms after autologous transplantation for multiple myeloma

✍ Scribed by E. Campagnaro; R. Saliba; K. Anderson; L. Roden; F. Mendoza; A. Aleman; C. Cleeland; D. Weber; J. Brown; S. Giralt

Book ID
116278777
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
82 KB
Volume
12
Category
Article
ISSN
1083-8791

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Symptom burden after autologous stem cel
Symptom burden after autologous stem cell transplantation for multiple myeloma
✍ Erica Campagnaro; Rima Saliba; Sergio Giralt; Linda Roden; Floralyn Mendoza; Ana πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 106 KB

## Abstract ## BACKGROUND Multiple myeloma (MM) is the most common indication for high‐dose chemotherapy with autologous stem cell transplantation (ASCT) in the U.S. and can be associated with substantial morbidity. Thorough assessment and understanding of symptoms and risk factors for symptom dev